ISBT BOOST VS IMRT BOOST IN CERVICAL CANCER PATIENTS
Phase 2
- Conditions
- Health Condition 1: C539- Malignant neoplasm of cervix uteri, unspecified
- Registration Number
- CTRI/2022/12/048293
- Lead Sponsor
- PGIMER, Chandigarh
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Willingness to give informed consent fulfilling either of the following criteria :
Advanced stage cervical cancer with extensive parametrial involvement, residual parametrical disease after EBRT, post hysterectomy gross residual disease, vaginal involvement.
Exclusion Criteria
Distorted pelvic anatomy, history of prior radiation, metastatic disease, uncontrolled medical comorbidities.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ocal disease control rates by examination with 2 techniquesTimepoint: At baseline, 1 month, 2 months and 6 months after treatment
- Secondary Outcome Measures
Name Time Method Acute and chronic toxicities with 2 techniquesTimepoint: 1,2 and 6 months